M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer

Nature Nanotechnology

Volumn 7, Issue 10, 2012, Pages 677-682

  Ghosh, Debadyuti ^a,b   Lee, Youjin ^a   Thomas, Stephanie ^c   Kohli, Aditya G ^a   Yun, Dong Soo ^a   Belcher, Angela M ^a,b   Kelly, Kimberly A ^c  

^a USA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c University of Virginia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; DIAGNOSIS; DISEASES; ENZYME ACTIVITY; GENE EXPRESSION; IMAGE ENHANCEMENT; IRON OXIDES; LIGANDS; MAGNETIC RESONANCE IMAGING; MAMMALS; MOLECULAR IMAGING; MOLECULES; NANOPARTICLES; PATIENT TREATMENT; PEPTIDES; PHAGE DISPLAY; SCAFFOLDS (BIOLOGY); SIGNAL TO NOISE RATIO; TUMORS;

ELECTRICAL AND MAGNETIC PROPERTY; HIGH THROUGHPUT SCREENING; MAGNETIC NANO-PARTICLES; MOLECULAR DETECTION; MONODISPERSE IRON OXIDE MAGNETIC NANOPARTICLES; PROTEIN INTERACTION; TARGETING CAPABILITY; TARGETING MOLECULES;

NANOMAGNETICS;

CONTRAST MEDIUM; CROSSLINKED IRON OXIDE; IRON OXIDE; IRON OXIDE NANOPARTICLE; LIGAND; MAGNETIC NANOPARTICLE; MION 46; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIOPHAGE M13; CANCER CELL; COMPLEX FORMATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GENE TARGETING; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; LIGHT SCATTERING; MALE; MOLECULAR IMAGING; MOUSE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL NOISE RATIO; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84871096796     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2012.146     Document Type: Article

References (32)

1. Weissleder, R. Molecular imaging in cancer. Science STKE 312, 1168-1171 (2006).
2. Massoud, T. & Gambhir, S. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580 (2003).
3. Gu, F. et al. Precise engineering of targeted nanoparticles by using selfassembled biointegrated block copolymers. Proc. Natl Acad. Sci. USA 105, 2586-2591 (2008).
4. Hamblett, K. J. et al. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin. Cancer Res. 10, 7063-7070 (2004).
5. Hlavacek, W., Posner, R. & Perelson, A. Steric effects on multivalent ligandreceptor binding: exclusion of ligand sites by bound cell surface receptors. Biophys. J. 76, 3031-3043 (1999).
6. Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188, 759-768 (2010).
7. Scott, J. K. & Smith, G. P. Searching for peptide ligands with an epitope library. Science 249, 386-390 (1990).
8. Larocca, D., Witte, A., Johnson, W., Pierce, G. F. & Baird, A. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum. Gene Ther. 9, 2393-2399 (1998).
9. Frenkel, D. & Solomon, B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl Acad. Sci. USA 99, 5675-5679 (2002).
10. Barry, M. A., Dower, W. J. & Johnston, S. A. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nature Med. 2, 299-305 (1996).
11. Arap, W., Pasqualini, R. & Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377-380 (1998).
12. Mao, C. B. et al. Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 303, 213-217 (2004).
13. Lee, Y. J. et al. Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes. Science 324, 1051-1055 (2009).
14. Nam, Y. S. et al. Biologically templated photocatalytic nanostructures for sustained light-driven water oxidation. Nature Nanotech. 5, 340-344 (2010).
15. Kelly, K. A., Waterman, P. & Weissleder, R. In vivo imaging of molecularly targeted phage. Neoplasia 8, 1011-1018 (2006).
16. Clark, C. J. & Sage, E. H. A prototypic matricellular protein in the tumor microenvironment - where there's SPARC, there's fire. J. Cell Biochem. 104, 721-732 (2008).
17. Yoo, P. J. et al. Spontaneous assembly of viruses on multilayered polymer surfaces. Nature Mater. 5, 234-240 (2006).
18. Park, J. et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nature Mater. 3, 891-895 (2004).
19. Shen, T., Weissleder, R., Papisov, M., Bogdanov, A. Jr & Brady, T. J. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 29, 599-604 (1993).
20. Fan, X. et al. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn. Reson. Med. 45, 1046-1055 (2001).
21. Lee, N. et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc. Natl Acad. Sci. USA 108, 2662-2667 (2011).
22. Jung, C. W. & Jacobs, P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13, 661-674 (1995).
23. Brekken, R. & Sage, E. SPARC, a matricellular protein: At the crossroads of cell-matrix. Matrix Biol. 19, 569-580 (2000).
24. Lee, J. H. et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Med. 13, 95-99 (2007).
25. Yoon, T. J., Lee, H., Shao, H. & Weissleder, R. Highly magnetic core-shell nanoparticles with a unique magnetization mechanism. Angew. Chem. Int. Ed. Engl. 50, 4663-4666 (2011).
26. Haun, J. B., Devaraj, N. K., Hilderbrand, S. A., Lee, H. & Weissleder, R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nature Nanotech. 5, 660-665 (2010).
27. von Maltzahn, G. et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nature Mater. 10, 545-552 (2011).
28. Pasqualini, R. & Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 380, 364-366 (1996).
29. Laakkonen, P., Porkka, K., Hoffman, J. & Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nature Med. 8, 751-755 (2002).
30. Kelly, K. et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 96, 327-336 (2005).
31. Schellenberger, E. A., Sosnovik, D., Weissleder, R. & Josephson, L. Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 15, 1062-1067 (2004).
32. Kellar, K. E. et al. Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA. Acad. Radiol. 9 (Suppl 1), S34-37 (2002).